Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Abstract B046: Multimodal biomarkers that predict the presence of Gleason pattern 4: Potential impact for active surveillance

Cancer Res (2023) 83 (11_Supplement): B046.

https://doi.org/10.1158/1538-7445.PRCA2023-B046

Published: 02 June 2023

View articletitled, Abstract B046: Multimodal biomarkers that predict the presence of Gleason pattern 4: Potential impact for active surveillance

Journal Articles

Abstract 3080: Characterization of steroid receptor mediated activation of GLI as driving force of breast cancer growth

Shabnam Massah, Maria Guo, Jane Foo, Ralph Buttyan, Artem Cherkasov, Nada Lallous

Cancer Res (2023) 83 (7_Supplement): 3080.

https://doi.org/10.1158/1538-7445.AM2023-3080

Published: 04 April 2023

View articletitled, Abstract 3080: Characterization of steroid receptor mediated activation of GLI as driving force of breast cancer growth

Journal Articles

Abstract 5283: Characterization of Gli activation by the estrogen receptor in breast cancer cells

Shabnam Massah, Jane Foo, Na Li, Sarah Truong, Mannan Nouri, Lishi Xie, Gail Prins, Ralph Buttyan, Nada Lallous, Artem Cherkasov

Cancer Res (2022) 82 (12_Supplement): 5283.

https://doi.org/10.1158/1538-7445.AM2022-5283

Published: 15 June 2022

View articletitled, Abstract 5283: Characterization of Gli activation by the estrogen receptor in breast cancer cells

Journal Articles

Abstract 4397: Gli Activation by Steroid Receptors in Prostate and Breast Cancer Cells

Shabnam Massah, Na Li, Sarah Truong, Jane Foo, Gail Prins, Ralph Buttyan

Cancer Res (2019) 79 (13_Supplement): 4397.

https://doi.org/10.1158/1538-7445.AM2019-4397

Published: 01 July 2019

View articletitled, Abstract 4397: Gli Activation by Steroid Receptors in Prostate and Breast Cancer Cells

Journal Articles

Abstract 4396: Gli, not Androgen Receptor, is the primary driver of prostate cell growth

Jane Foo, Na Li, Shabnam Massah, Mannan Nouri, Mike Wang, Ralph Buttyan

Cancer Res (2019) 79 (13_Supplement): 4396.

https://doi.org/10.1158/1538-7445.AM2019-4396

Published: 01 July 2019

View articletitled, Abstract 4396: Gli, not Androgen Receptor, is the primary driver of prostate cell growth

Journal Articles

Abstract 1087: Semaphorin 3C drives invasiveness in prostate cells through epithelial-to-mesenchymal transition and stemness

Kevin J. Tam, Daniel H. Hui, Wilson C. Lee, Mingshu Dong, Tabitha Tombe, Ivy Z. Jiao, Shahram Khosravi, Ario Takeuchi, James W. Peacock, Larissa Ivanova, Igor Moskalev, Martin E. Gleave, Ralph Buttyan, Michael E. Cox, Christopher J. Ong

Cancer Res (2018) 78 (13_Supplement): 1087.

https://doi.org/10.1158/1538-7445.AM2018-1087

Published: 01 July 2018

View articletitled, Abstract 1087: Semaphorin 3C drives invasiveness in prostate cells through epithelial-to-mesenchymal transition and stemness

Journal Articles

Abstract 5239: Gli is a primary driver of prostate cancer cell growth

Na Li, Jackson Moore, Sarah Troung, Mannan Nouri, Jane Foo, Ralph Buttyan

Cancer Res (2018) 78 (13_Supplement): 5239.

https://doi.org/10.1158/1538-7445.AM2018-5239

Published: 01 July 2018

View articletitled, Abstract 5239: Gli is a primary driver of prostate cancer cell growth

Journal Articles

Abstract 4908: Neuropilin-1 is up-regulated in the adaptive response of prostate tumors to androgen targeted therapies and is prognostic of metastatic progression and patient mortality

Cancer Res (2017) 77 (13_Supplement): 4908.

https://doi.org/10.1158/1538-7445.AM2017-4908

Published: 01 July 2017

View articletitled, Abstract 4908: Neuropilin-1 is up-regulated in the adaptive response of prostate tumors to androgen targeted therapies and is prognostic of metastatic progression and patient mortality

Journal Articles

Abstract 4492: Androgen receptor affects GLI activity by promoting transcriptionally active states of GLI upon androgen stimulation

Sarah Truong, Na Li, Mannan Nouri, Ralph Buttyan

Cancer Res (2017) 77 (13_Supplement): 4492.

https://doi.org/10.1158/1538-7445.AM2017-4492

Published: 01 July 2017

View articletitled, Abstract 4492: Androgen receptor affects GLI activity by promoting transcriptionally active states of GLI upon androgen stimulation

Journal Articles

Abstract C06: Multi-lineage differentiation potential of carcinoma-associated fibroblasts isolated from primary tumors of metastatic prostate cancer patients

Javier Cerda-Infante, Jenny Henríquez, Marianela Sánchez, Ralph Buttyan, Viviana P. Montecinos

Cancer Res (2016) 76 (15_Supplement): C06.

https://doi.org/10.1158/1538-7445.TME16-C06

Published: 28 July 2016

View articletitled, Abstract C06: Multi-lineage differentiation potential of carcinoma-associated fibroblasts isolated from primary tumors of metastatic prostate cancer patients

Journal Articles

Abstract 3344: Targeting the treatment-induced developmental reprogramming process that facilitates progression of prostate cancer

Mannan Nouri, Amy Anne Lubik, Josselin Caradec, Na Li, Sarah Truong, Brett G. Hollier, Ralph Buttyan

Cancer Res (2016) 76 (14_Supplement): 3344.

https://doi.org/10.1158/1538-7445.AM2016-3344

Published: 15 July 2016

View articletitled, Abstract 3344: Targeting the treatment-induced developmental reprogramming process that facilitates progression of prostate cancer

Journal Articles

Abstract 4073: Efficient conditional reprogramming of differentiated prostate cancer cells back to a stem cell-like state with increased aggressive properties

Josselin Caradec, Amy A. Lubik, Mannan Nouri, Na Li, Manuel Altimarano-Dimas, Jennifer Bishop, Mani Moniri, Down Cochrane, Martin Gleave, Ralph Buttyan

Cancer Res (2015) 75 (15_Supplement): 4073.

https://doi.org/10.1158/1538-7445.AM2015-4073

Published: 01 August 2015

View articletitled, Abstract 4073: Efficient conditional reprogramming of differentiated prostate cancer cells back to a stem cell-like state with increased aggressive properties

Journal Articles

Abstract 3017: A spontaneous developmental lineage plasticity that underlies the response of prostate cancer cells to androgen deprivation

Josselin Caradec*, Amy Lubik*, Mannan Nouri, Na Li, Jennifer Bishop, Martin Gleave, Ralph Buttyan

Cancer Res (2014) 74 (19_Supplement): 3017.

https://doi.org/10.1158/1538-7445.AM2014-3017

Published: 01 October 2014

View articletitled, Abstract 3017: A spontaneous developmental lineage plasticity that underlies the response of prostate cancer cells to androgen deprivation

Journal Articles

Abstract 5574: Gli2 protein and the AR operational switch to the castration resistant prostate cancer transcription program

Na Li, Ralph Buttyan, Sarah Truong, Yue Yu, Mengqian Chen

Cancer Res (2014) 74 (19_Supplement): 5574.

https://doi.org/10.1158/1538-7445.AM2014-5574

Published: 01 October 2014

View articletitled, Abstract 5574: Gli2 protein and the AR operational switch to the castration resistant prostate cancer transcription program

Journal Articles

Abstract 1632: Paracrine Hedgehog as a mediator of stromal cell steroidogenesis that contributes to progression of prostate cancer to castration resistant disease.

Amy A. Lubik, Hans Adomat, Emma S. Guns, Ralph Buttyan

Cancer Res (2013) 73 (8_Supplement): 1632.

https://doi.org/10.1158/1538-7445.AM2013-1632

Published: 15 April 2013

View articletitled, Abstract 1632: Paracrine Hedgehog as a mediator of stromal cell steroidogenesis that contributes to progression of prostate cancer to castration resistant disease.

Journal Articles

Abstract 400: Coordinated loss of CD9 and IGSF8 expression on the prostate cancer cell surface contributes to metastasis and hormone responsiveness.

Na Li, Ladan Fazli, Estelle Li, Ralph Buttyan

Cancer Res (2013) 73 (8_Supplement): 400.

https://doi.org/10.1158/1538-7445.AM2013-400

Published: 15 April 2013

View articletitled, Abstract 400: Coordinated loss of CD9 and IGSF8 expression on the prostate cancer cell surface contributes to metastasis and hormone responsiveness.

Journal Articles

Abstract 1294: Identification of the binding domains that allow ligand-independent co-activation of androgen receptor by Gli2.

Na Li, Mengqian Chen, Ralph Buttyan

Cancer Res (2013) 73 (8_Supplement): 1294.

https://doi.org/10.1158/1538-7445.AM2013-1294

Published: 15 April 2013

View articletitled, Abstract 1294: Identification of the binding domains that allow ligand-independent co-activation of androgen receptor by Gli2.

Journal Articles

Abstract 1494: Silencing Notch-1 and Notch-3 promotes epithelial-to-mesenchymal transition (EMT) and self-renewal potential in human bladder cancer.

Wolfgang Jaeger, Tetsutaro Hayashi, Shannon Awrey, Kilian Gust, Thomas Cordonnier, Na Li, Ralph Buttyan, Estelle Li, Ladan Fazli, Theodorus Van Der Kwast, Bas W. G. Van Rhijn, Peter C. Black

Cancer Res (2013) 73 (8_Supplement): 1494.

https://doi.org/10.1158/1538-7445.AM2013-1494

Published: 15 April 2013

View articletitled, Abstract 1494: Silencing Notch-1 and Notch-3 promotes epithelial-to-mesenchymal transition (EMT) and self-renewal potential in human bladder cancer.

Journal Articles

Class III β-Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy

Guillaume Ploussard, Stéphane Terry, Pascale Maillé, Yves Allory, Nanor Sirab, Laurence Kheuang, Pascale Soyeux, Nathalie Nicolaiew, Estelle Coppolani, Bernard Paule, Laurent Salomon, Stéphane Culine, Ralph Buttyan, Francis Vacherot, Alexandre de la Taille

Cancer Res (2010) 70 (22): 9253–9264.

https://doi.org/10.1158/0008-5472.CAN-10-1447

Published: 14 November 2010

View articletitled, Class III β-Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy

Includes: Supplementary data

Journal Articles

Abstract 5472: Class III beta-tubulin in castration resistant human prostate cancer

Stephane Terry, Guillaume Ploussard, Pascale Maillé, Yves Allory, Nathalie Nicolaiew, Pascale Soyeux, Laurence Kheuang, Stephane Culine, Ralph Buttyan, Alexandre de la Taille, Francis Vacherot

Cancer Res (2010) 70 (8_Supplement): 5472.

https://doi.org/10.1158/1538-7445.AM10-5472

Published: 15 April 2010

View articletitled, Abstract 5472: Class III beta-tubulin in castration resistant human prostate cancer

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract B046: Multimodal biomarkers that predict the presence of Gleason pattern 4: Potential impact for active surveillance

Abstract 3080: Characterization of steroid receptor mediated activation of GLI as driving force of breast cancer growth

Abstract 5283: Characterization of Gli activation by the estrogen receptor in breast cancer cells

Abstract 4397: Gli Activation by Steroid Receptors in Prostate and Breast Cancer Cells

Abstract 4396: Gli, not Androgen Receptor, is the primary driver of prostate cell growth

Abstract 1087: Semaphorin 3C drives invasiveness in prostate cells through epithelial-to-mesenchymal transition and stemness

Abstract 5239: Gli is a primary driver of prostate cancer cell growth

Abstract 4908: Neuropilin-1 is up-regulated in the adaptive response of prostate tumors to androgen targeted therapies and is prognostic of metastatic progression and patient mortality

Abstract 4492: Androgen receptor affects GLI activity by promoting transcriptionally active states of GLI upon androgen stimulation

Abstract C06: Multi-lineage differentiation potential of carcinoma-associated fibroblasts isolated from primary tumors of metastatic prostate cancer patients

Abstract 3344: Targeting the treatment-induced developmental reprogramming process that facilitates progression of prostate cancer

Abstract 4073: Efficient conditional reprogramming of differentiated prostate cancer cells back to a stem cell-like state with increased aggressive properties

Abstract 3017: A spontaneous developmental lineage plasticity that underlies the response of prostate cancer cells to androgen deprivation

Abstract 5574: Gli2 protein and the AR operational switch to the castration resistant prostate cancer transcription program

Abstract 1632: Paracrine Hedgehog as a mediator of stromal cell steroidogenesis that contributes to progression of prostate cancer to castration resistant disease.

Abstract 400: Coordinated loss of CD9 and IGSF8 expression on the prostate cancer cell surface contributes to metastasis and hormone responsiveness.

Abstract 1294: Identification of the binding domains that allow ligand-independent co-activation of androgen receptor by Gli2.

Abstract 1494: Silencing Notch-1 and Notch-3 promotes epithelial-to-mesenchymal transition (EMT) and self-renewal potential in human bladder cancer.

Class III β-Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy

Abstract 5472: Class III beta-tubulin in castration resistant human prostate cancer

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only